Veracyte, Inc.
VCYT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $24,138 | -$74,404 | -$36,560 | -$75,563 |
| Dep. & Amort. | $23,459 | $27,188 | $25,928 | $19,593 |
| Deferred Tax | -$233 | -$3,839 | $133 | -$6,258 |
| Stock-Based Comp. | $36,249 | $33,141 | $26,734 | $22,519 |
| Change in WC | -$21,319 | -$4,163 | -$16,381 | $4,219 |
| Other Non-Cash | $12,802 | $66,299 | $7,681 | $3,869 |
| Operating Cash Flow | $75,096 | $44,222 | $7,535 | -$31,621 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,287 | -$9,961 | -$8,549 | -$5,376 |
| Net Acquisitions | $5,012 | $0 | $0 | -$736,830 |
| Inv. Purchases | -$50,000 | -$19,700 | -$33,519 | $162,419 |
| Inv. Sales/Matur. | $0 | $44,773 | $12,681 | $3,000 |
| Other Inv. Act. | $0 | $0 | $0 | -$162,419 |
| Investing Cash Flow | -$56,275 | $15,112 | -$29,387 | -$739,206 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$1,281 | $0 |
| Stock Issued | $19,993 | $0 | $0 | $593,821 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$15,089 | $2,837 | $4,775 | $2,499 |
| Financing Cash Flow | $4,904 | $2,837 | $3,494 | $596,320 |
| Forex Effect | -$424 | $163 | -$592 | -$1,514 |
| Net Chg. in Cash | $23,301 | $62,334 | -$18,950 | -$176,021 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $217,330 | $154,996 | $173,946 | $349,967 |
| End Cash | $240,631 | $217,330 | $154,996 | $173,946 |
| Free Cash Flow | $63,809 | $34,261 | -$1,014 | -$36,997 |